CAPRICOR THERAPEUTICS, INC.
CAPRNasdaq
$19.44
↑ +1.7%Jul 17 close · end-of-day
Price
1Y↑ +168.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.1B
Enterprise Value
$837.9M
P/E
—
P/S
—
P/B
4.0
EV/EBITDA
—
PEG
—
FCF Yield
-8.9%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$114.6M
Free Cash Flow (TTM)
-$99.8M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-41.1%
ROIC
-102186.5%
Debt / Equity
—
Net Cash
$278.6M
Return 1Y
+171.5%
Company profile
Management & directors
- Bergmann AnthonyCHIEF FINANCIAL OFFICER
- Krasney KarenEVP, GENERAL COUNSEL
Roles derived from SEC Form 4 filings.
Earnings
CAPR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.59↑ +11.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $310,250.00 | $244,898.00 | $2.6M | $25.2M | $22.3M | $0.00 |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$13.7M | -$20.9M | -$29.7M | -$24.1M | -$42.6M | -$108.1M |
| Net income | -$13.7M | -$20.0M | -$29.0M | -$22.3M | -$40.5M | -$105.0M |
| Diluted EPS | -$0.88 | -$0.87 | -$1.18 | -$0.83 | -$1.15 | -$2.26 |
| Operating cash flow | -$10.1M | -$16.8M | $4.9M | -$25.6M | -$40.0M | -$69.8M |
| Free cash flow | -$10.6M | -$18.0M | $2.9M | -$26.9M | -$41.2M | -$72.7M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -4412.6% | -8549.9% | -1163.9% | -95.6% | -191.1% | — |
| Net margin | -4401.9% | -8175.9% | -1137.4% | -88.5% | -181.7% | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0M | $2.3M | $11.1M | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$11.6M | -$13.0M | -$7.7M | -$25.0M | -$27.7M | -$26.3M | -$29.2M | -$36.8M |
| Net income | -$11.0M | -$12.6M | -$7.1M | -$24.4M | -$25.9M | -$24.6M | -$30.2M | -$33.9M |
| Diluted EPS | -$0.35 | -$0.38 | -$0.11 | -$0.53 | -$0.57 | -$0.54 | -$0.62 | -$0.59 |
| Operating cash flow | -$12.3M | -$11.6M | -$14.8M | -$6.4M | -$20.1M | -$19.7M | -$23.6M | -$29.3M |
| Free cash flow | -$12.3M | -$11.7M | -$15.3M | -$7.3M | -$20.4M | -$19.7M | -$25.2M | -$34.4M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -291.9% | -575.2% | -69.1% | — | — | — | — | — |
| Net margin | -277.0% | -555.2% | -63.9% | — | — | — | — | — |
Company news
Coming soonHeadlines for CAPR will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-25 | Krasney Karen· EVP, GENERAL COUNSEL | Sale | 24,100 | $30.38 | $732,158.00 | filing |
| 2026-06-25 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Sale | 24,100 | $30.38 | $732,158.00 | filing |
| 2026-06-25 | Krasney Karen· EVP, GENERAL COUNSEL | Option exercise | 24,100 | $3.18 | $76,638.00 | filing |
| 2026-06-25 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Option exercise | 24,100 | $3.18 | $76,638.00 | filing |
| 2026-06-24 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Sale | 400 | $30.00 | $12,000.00 | filing |
| 2026-06-24 | Krasney Karen· EVP, GENERAL COUNSEL | Sale | 400 | $30.00 | $12,000.00 | filing |
| 2026-06-24 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Option exercise | 400 | $3.18 | $1,272.00 | filing |
| 2026-06-24 | Krasney Karen· EVP, GENERAL COUNSEL | Option exercise | 400 | $3.18 | $1,272.00 | filing |
| 2026-06-22 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Sale | 500 | $30.00 | $15,000.00 | filing |
| 2026-06-22 | Krasney Karen· EVP, GENERAL COUNSEL | Sale | 500 | $30.00 | $15,000.00 | filing |
| 2026-06-22 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Option exercise | 500 | $3.18 | $1,590.00 | filing |
| 2026-06-22 | Krasney Karen· EVP, GENERAL COUNSEL | Option exercise | 500 | $3.18 | $1,590.00 | filing |
| 2026-05-18 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Option exercise | 3,000 | $1.39 | $4,170.00 | filing |
| 2026-05-13 | Litvack Frank | Option exercise | 3,937 | $1.39 | $5,472.43 | filing |
| 2026-05-01 | Krasney Karen· EVP, GENERAL COUNSEL | Sale | 25,000 | $31.70 | $792,547.50 | filing |
| 2026-05-01 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Sale | 25,000 | $31.70 | $792,540.00 | filing |
| 2026-05-01 | Krasney Karen· EVP, GENERAL COUNSEL | Option exercise | 25,000 | $3.18 | $79,500.00 | filing |
| 2026-05-01 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Option exercise | 25,000 | $3.18 | $79,500.00 | filing |
| 2026-04-02 | Sabar Karimah Es | Sale | 7,529 | $32.00 | $240,928.00 | filing |
| 2026-04-02 | Sabar Karimah Es | Option exercise | 7,529 | $3.18 | $23,942.22 | filing |
| 2026-04-01 | Sabar Karimah Es | Sale | 53,735 | $31.03 | $1.7M | filing |
| 2026-04-01 | Sabar Karimah Es | Option exercise | 53,735 | $4.86 | $261,152.10 | filing |
| 2026-03-31 | Sabar Karimah Es | Sale | 61,265 | $30.17 | $1.8M | filing |
| 2026-03-31 | Bergmann Anthony· CHIEF FINANCIAL OFFICER | Sale | 25,000 | $30.13 | $753,152.50 | filing |
| 2026-03-31 | Krasney Karen· EVP, GENERAL COUNSEL | Sale | 25,000 | $30.12 | $752,935.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.